In order to better understand the etiology of human IR and its progression to T2D and determine the clinical efficacy of Nrf2 inducers, further cohort studies would be required to characterize the interaction of genetic and environmental factors, including obesity and aging (Figure 7). This evidence concerns the gene NFE2L2 and obesity disorder.